Inhibrx Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INBX and other ETFs, options, and stocks.About INBX
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function.
CEOMark Paul Lappe
CEOMark Paul Lappe
Employees161
Employees161
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2024
Founded2024
Employees161
Employees161
INBX Key Statistics
Market cap196.15M
Market cap196.15M
Price-Earnings ratio0.11
Price-Earnings ratio0.11
Dividend yield—
Dividend yield—
Average volume97.66K
Average volume97.66K
High today$13.89
High today$13.89
Low today$13.14
Low today$13.14
Open price$13.27
Open price$13.27
Volume73.85K
Volume73.85K
52 Week high$18.95
52 Week high$18.95
52 Week low$10.80
52 Week low$10.80
People also own
Based on the portfolios of people who own INBX. This list is generated using Robinhood data, and it’s not a recommendation.